400 related articles for article (PubMed ID: 29400692)
61. Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway.
Kong D; Jiang Y; Miao X; Wu Z; Liu H; Gong W
Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166267. PubMed ID: 34508829
[TBL] [Abstract][Full Text] [Related]
62. Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.
Hyun J; Al Abo M; Dutta RK; Oh SH; Xiang K; Zhou X; Maeso-Díaz R; Caffrey R; Sanyal AJ; Freedman JA; Patierno SR; Moylan CA; Abdelmalek MF; Diehl AM
J Hepatol; 2021 Sep; 75(3):623-633. PubMed ID: 33964370
[TBL] [Abstract][Full Text] [Related]
63. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
[TBL] [Abstract][Full Text] [Related]
64. MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression.
Jiang Y; Zhang Y; Leung JY; Fan C; Popov KI; Su S; Qian J; Wang X; Holtzhausen A; Ubil E; Xiang Y; Davis I; Dokholyan NV; Wu G; Perou CM; Kim WY; Earp HS; Liu P
Nat Commun; 2019 Apr; 10(1):1515. PubMed ID: 30944303
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
66. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
67. Correlation between loss of PTEN expression and PKB/AKT phosphorylation in hepatocellular carcinoma.
Yang Z; Yi J; Li X; Long W
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):45-7. PubMed ID: 15934306
[TBL] [Abstract][Full Text] [Related]
68. Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis.
Kushner JA; Simpson L; Wartschow LM; Guo S; Rankin MM; Parsons R; White MF
J Biol Chem; 2005 Nov; 280(47):39388-93. PubMed ID: 16170201
[TBL] [Abstract][Full Text] [Related]
69. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
70. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.
Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT
Virol J; 2015 Feb; 12():12. PubMed ID: 25645159
[TBL] [Abstract][Full Text] [Related]
72. Core Hippo pathway components act as a brake on Yap and Taz in the development and maintenance of the biliary network.
Brandt ZJ; Echert AE; Bostrom JR; North PN; Link BA
Development; 2020 Jun; 147(12):. PubMed ID: 32439761
[TBL] [Abstract][Full Text] [Related]
73. Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway.
Xu Z; Hu J; Cao H; Pilo MG; Cigliano A; Shao Z; Xu M; Ribback S; Dombrowski F; Calvisi DF; Chen X
Exp Mol Med; 2018 Jan; 50(1):e417. PubMed ID: 29303510
[TBL] [Abstract][Full Text] [Related]
74. Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten.
Yeh ES; Belka GK; Vernon AE; Chen CC; Jung JJ; Chodosh LA
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6103-8. PubMed ID: 23520049
[TBL] [Abstract][Full Text] [Related]
75. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
[TBL] [Abstract][Full Text] [Related]
76. TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression.
Hwang JH; Kim AR; Kim KM; Il Park J; Oh HT; Moon SA; Byun MR; Jeong H; Kim HK; Yaffe MB; Hwang ES; Hong JH
Nat Commun; 2019 Jan; 10(1):421. PubMed ID: 30679431
[TBL] [Abstract][Full Text] [Related]
77. YAP-TEAD up-regulates IRS2 expression to induce and deteriorate oesophageal cancer.
Xu X; Nie J; Lu L; Du C; Meng F; Song D
J Cell Mol Med; 2021 Mar; 25(5):2584-2595. PubMed ID: 33570213
[TBL] [Abstract][Full Text] [Related]
78. PTEN at the crossroad of metabolic diseases and cancer in the liver.
Vinciguerra M; Foti M
Ann Hepatol; 2008; 7(3):192-9. PubMed ID: 18772845
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic restriction of Hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells.
Wang T; Qin ZY; Wen LZ; Guo Y; Liu Q; Lei ZJ; Pan W; Liu KJ; Wang XW; Lai SJ; Sun WJ; Wei YL; Liu L; Guo L; Chen YQ; Wang J; Xiao HL; Bian XW; Chen DF; Wang B
Cell Death Differ; 2018 Dec; 25(12):2086-2100. PubMed ID: 29555977
[TBL] [Abstract][Full Text] [Related]
80. GPCR-Hippo Signaling in Cancer.
Luo J; Yu FX
Cells; 2019 May; 8(5):. PubMed ID: 31072060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
